Cisplatin, gemcitabine, and treosulfan in relapsed stage IV cutaneous malignant melanoma patients

To evaluate the efficacy of cisplatin, gemcitabine, and treosulfan (CGT) in 91 patients with pretreated relapsed AJCC stage IV cutaneous malignant melanoma. Patients in relapse after first-, second-, or third-line therapy received 40 mg m(−2) intravenous (i.v.) cisplatin, 1000 mg m(−2) i.v. gemcitab...

Descripción completa

Detalles Bibliográficos
Autores principales: Atzpodien, J, Terfloth, K, Fluck, M, Reitz, M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2007
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360238/
https://www.ncbi.nlm.nih.gov/pubmed/17971774
http://dx.doi.org/10.1038/sj.bjc.6604045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360238/
https://www.ncbi.nlm.nih.gov/pubmed/17971774
http://dx.doi.org/10.1038/sj.bjc.6604045

Ejemplares similares